Oklo Speeds Up Nuclear Deployment with Key DOE Partnerships
Oklo reports strong 3Q 2025 progress, focusing on accelerating reactor timelines through key DOE partnerships, starting construction at Aurora-INL, and securing a major fuel strategy.
NOTRELOAD AI
Trump Administration Promises Lower Coffee and Fruit Prices
Treasury Secretary Scott Bessent says the Trump administration will take steps soon to lower prices on coffee, bananas, and other imported foods amid rising grocery costs.
Jefferies Raises Price Target for Alto Neuroscience to $25
Jefferies boosts Alto Neuroscience price target to $25, citing upcoming Phase II data and investor interest in its precision psychiatry treatments.
Truist Says Alkermes’ Alixorexton Data Lacks Detail Despite Phase 2 Success
Truist comments on Alkermes’ Phase 2 Vibrance-2 trial of alixorexton in narcolepsy type 2, noting "limited" details but strong patient engagement and maintaining a Buy rating with a $50 target.
Citi Boosts Eli Lilly Price Target to $1,500 on Strong Weight Loss Outlook
Citi raises Eli Lilly’s price target to $1,500, citing growing dominance in the weight loss market after a Medicare and Medicaid access deal and over $40B in potential peak sales.
Baytex Sells U.S. Eagle Ford Assets for C$3.25B to Fund Canada Focus
Baytex sells its U.S. Eagle Ford assets for C$3.25B, becoming a focused, high-return Canadian energy producer. Proceeds strengthen the balance sheet.